There’s been a small bump in the road in Cyclopharm’s (ASX: CYC) plans to secure regulatory approval for Technegas™, their…
Sadly, 1 in 7 women will be diagnosed with breast cancer at some stage in their life. That's 1 in…
Digital technology transformation company Empired (ASX: EPD) does a lot. In a nutshell, the international tech company helps organisations transform…
45% of people living with asthma have poor control of their condition which in turn, impacts their quality of life.…
Spending a mind numbing amount of time at home, as a locked down Victorian is wont to do sends you…
Bloating, weight gain, mood swings, headaches. Just a handful of the not so lovely side effects bestowed upon women by…